Evidence map›Paper›PMID 26201744›Full record

ArticleNature chemistry2015

An oxazetidine amino acid for chemical protein synthesis by rapid, serine-forming ligations.

Ivano Pusterla, Jeffrey W Bode

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Total synthesis of interleukin-2Chemical science · 2023
    Article
  7. Article
  8. Chemical synthesis ofRSC chemical biology · 2022
    Article
  9. Article
  10. Approaches for peptide and protein cyclisation.Organic & biomolecular chemistry · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Native Serine Peptide Assembly: Scope and Utility.European journal of organic chemistry · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Ivano PusterlaDepartment of Chemistry and Applied Biosciences, Laboratorium für Organische Chemie, Vladimir Prelog Weg 3, ETH Zürich, Zürich 8093, Switzerland.
Jeffrey W Bode1] Department of Chemistry and Applied Biosciences, Laboratorium für Organische Chemie, Vladimir Prelog Weg 3, ETH Zürich, Zürich 8093, Switzerland [2] Institute of Transformative Bio-Molecules (WPI-ITbM), Nagoya University, Chikusa, Nagoya 464-8602, Japan.
ETH Zurich · CHNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amide-forming ligation reactions allow the chemical synthesis of proteins by the union of unprotected peptide segments, and enable the preparation of protein derivatives not accessible by expression or bioengineering approaches. The native chemical ligation (NCL) of thioesters and N-terminal cysteines is unquestionably the most successful approach, but is not ideal for all synthetic targets. Here we describe the synthesis of an Fmoc-protected oxazetidine amino acid for use in the α-ketoacid-hydroxylamine (KAHA) amide ligation. When incorporated at the N-terminus of a peptide segment, this four-membered cyclic hydroxylamine can be used for rapid serine-forming ligations with peptide α-ketoacids. This ligation operates at low concentration (100 μM-5 mM) and mild temperatures (20-25 °C). The utility of the reaction was demonstrated by the synthesis of S100A4, a 12 kDa calcium-binding protein not easily accessible by NCL or other amide-forming reactions due to its primary sequence and properties.

Indexed as

Amino AcidsAmino Acid SequenceFluorenesHydroxylamineProteinsSerineAmino AcidsFluorenesHydroxylamineN(alpha)-fluorenylmethyloxycarbonylamino acidsProteinsSerine

Identifiers

PMID26201744
OpenAlexW1021258555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.